Company Overview and News

 
South32 to fund Inca Minerals’ Riqueza project for 60% stake

2018-04-05 australianmining.com.au
South32 is to fund a geophysical survey at Inca Minerals’ ambitious Greater Riqueza zinc-silver-lead project in Peru in return for a 60 per cent earn-in on the project.
Upvote Downvote

 
Emergent and Inca top the ASX Volume Leaders, as one heads north and the other south

2017-10-27 proactiveinvestors.com.au
Emergent Resources Ltd (ASX:EMG) is the most active stock on the ASX today, trading 62 million shares by midday, with its shares jumping 88% to $0.015.
Upvote Downvote

 
Inca Minerals to attract funds for high grade zinc-silver-lead in Peru

2017-10-25 proactiveinvestors.com.au
Inca Minerals Ltd (ASX:ICG) is currently raising funds to continue exploring high grade zinc-silver-lead deposits in Peru.
Upvote Downvote

 
Inca finds strong mineralisation at Cerro Rayas

2017-10-25 australianmining.com.au
Australian producer Inca Minerals has discovered strong mineralisation returns for zinc, lead and silver at a 1.5km corridor at its Cerro Rayas project in Peru.
Upvote Downvote

 
Inca Minerals to attract funds for high grade zinc-silver-lead Peru

2017-10-25 proactiveinvestors.com.au
Inca Minerals Ltd (ASX:ICG) is currently raising funds to continue exploring high grade zinc-silver-lead deposits in Peru.
Upvote Downvote

 
Inca Minerals tops the ASX Most Active following zinc assays

2017-10-06 proactiveinvestors.com.au
Inca Minerals Ltd (ASX:ICG) has exited a trading halt at speed today, with the stock the most active on the ASX with 41 million changing hands, while also delivering a 42.9% gain to $0.01.
Upvote Downvote

 
Inca Minerals eyes zinc in Peru

2017-03-17 proactiveinvestors.com.au
Inca Minerals (ASX:ICG) has been granted a trading halt by the ASX, with its shares placed in pre-open.
Upvote Downvote

 
Inca Minerals heads to market

2017-02-02 proactiveinvestors.com.au
The halt will remain in place until the opening of trade on Tuesday 7th February 2017, or earlier if an announcement is made to the market.
Upvote Downvote

 
The zinc price is on the rise, but which companies are set to benefit the most?

2017-01-26 proactiveinvestors.com.au
Balkan Zinc looks set to be the first zinc miner to list in London - if not quite in living memory, then at least in a long, long while.
Upvote Downvote

 
Inca Minerals Ltd samples high-grade zinc, silver and lead in Peru

2016-11-29 proactiveinvestors.com.au
Cerro Rayas is the company’s second zinc-silver-lead focussed project in Peru, located 15 kilometres from its Riqueza project. The program focussed on two old mine workings, Vilcapuquio in the north of the concession and Wari in the south. The rock chip sample assay results from both the Wari and Vilcapuquio were encouraging. Based on assay results, Wari is strongly mineralised in zinc, silver and lead with averages of 30.
Upvote Downvote

 
Inca Minerals Ltd to lift cash position

2016-11-10 proactiveinvestors.com.au
The halt will remain in place until the opening of trade on Monday 14th November 2016, or earlier if an announcement is made to the market.
Upvote Downvote

 
Inca Minerals Ltd is the ASX Volume Leader late in the trading session

2016-09-29 proactiveinvestors.com.au
Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX emerging companies with distribution in Australia, UK, North America and Hong Kong / China.
Upvote Downvote

 
Inca Minerals Ltd tops ASX Most Traded at the close

2016-09-21 proactiveinvestors.com.au
Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX emerging companies with distribution in Australia, UK, North America and Hong Kong / China.
Upvote Downvote

 
BCGold Corp. Provides Peru Exploration Update and Closes Private Placement

2016-09-21 marketwired
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Sept. 20, 2016) - BCGold Corp. (TSX VENTURE:BCG) ("BCGold" or the "Company") is pleased to announce that Phase I exploration has commenced at the Company's 100% owned Pucacorral property, situated in the San Mateo mining district in east-central Peru. Phase I exploration will consist of geological mapping, prospecting and sampling, on both surface and underground in the San Mateo mine.
Upvote Downvote

 
Inca Minerals Ltd to reveal assays

2016-09-19 proactiveinvestors.com.au
Inca Minerals Ltd (ASX:ICG) has been granted a trading halt by the ASX this morning, pending sampling assay results. No further information has yet been provided. Last week the company said that it had recently completed its third mapping and sampling exploration program at Riqueza in Peru, and expects to announce further results from that program within 10 – 14 days. The halt will remain in place until the opening of trade on Wednesday 21st September 2016, or earlier if an announcement is made to the market.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...